Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 16, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 17, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001790340-26-000082
Filed / recorded
Jul 17, 2026, 8:29 PM UTC
Added to OQRO
Oct 7, 2026, 11:38 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Immuneering Corp
Issuer CIK
1790340
Ticker
IMRX
Reporting person
Andrew Gengos
Relationship
Officer
Officer title
Chief Financial Officer
Security
Stock Option
Table
Derivative (Table II)
Transaction date
Jul 16, 2026
Transaction code
A
Shares / units
650,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
650,000
Ownership form
Direct
Amendment
No
Footnotes from the filing
Subject to the reporting person's continued employment through each applicable vesting date, 8.33333% of the shares underlying the stock option shall vest on each of the first, second and third monthly anniversary of the grant transaction date (the "Grant Date"); 1.6667% of the shares underlying the stock option shall vest on the fourth monthly anniversary of the Grant Date and on each monthly anniversary thereafter until the one year anniversary of the Grant Date; 3.33333% of the shares underlying the stock option shall vest on each monthly anniversary following the one-year anniversary of the Grant Date until the second anniversary of the Grant Date; and 0.833333% of the of the shares underlying the stock option shall vest on each monthly anniversary following the second anniversary of the Grant Date until the fourth anniversary of the Grant Date, such that all shares underlying the stock option shall be fully vested on the fourth anniversary of the Grant Date.
Their largest buy since 2021Traded Jun 15 · filed 1 day later
Immuneering's CHIEF SCIENTIFIC OFFICER paid $25K out of pocket for Immuneering shares. 1 other person at Immuneering bought some too, in the same month.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.